ReviewDiagnostics (Basel, Switzerland)2022

Cancer Immunotherapy with Immune Checkpoint Inhibitors-Biomarkers of Response and Toxicity; Current Limitations and Future Promise.

Brian Healey Bird et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.